Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaseem Shaikh

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Nature|July 1, 2026
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cellsNeil Savage, Shan Grewal, Muhammad Vaseem Shaikh, et al.
Nature Medicine|August 2, 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cellsChirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Science Translational Medicine|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell targetWilliam T Maich, Muhammad Vaseem Shaikh, Anish Puri, et al.
Nature|July 1, 2026
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cellsNeil Savage, Shan Grewal, Muhammad Vaseem Shaikh, et al.
Nature Medicine|August 2, 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cellsChirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, et al.
Pageof 2